Clin2
NCT07456696Likely a fitRecruiting

TSND-201 for PTSD treatment study

Post Traumatic Stress Disorder

Part of Mental health clinical trials.

This trial tests if an investigational drug called TSND-201 can help treat PTSD. It is for people who have tried at least one other PTSD treatment before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a current PTSD diagnosis that has lasted at least 6 months
  • You have tried at least one medication or therapy for PTSD before
  • You are able to communicate well in English (both speaking and reading)
  • You do not have any other major medical or mental health conditions
  • Your body mass index (BMI) is between 18 and 40

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07836647Recruiting· Phase 3
Study of a new drug for post-traumatic stress disorder

This study tests a new medication, TSND-201, to see if it is safe and effective for people living with PTSD. It is for adults who have already tried at least one other treatment and are looking for a new option.

Denver, Colorado
NCT07670702Enrolling by invitation· Phase 3
Long-term safety and effectiveness of TSND-201 for PTSD

This trial checks the long-term safety and how well TSND-201, a study drug, helps people with PTSD. It is for patients who already completed a previous TSND-201 study and did well.

Little Rock, Arkansas
NCT07079761Recruiting· Phase 2
PTSD treatment study with a hormone-like drug

This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.

Boston, Massachusetts
NCT07664631Not yet recruiting· Phase 1
Stimulant medication study for PTSD

This study tests whether a stimulant medication can help reduce PTSD symptoms. If you have PTSD and are generally healthy, you might be able to join.

Chicago, Illinois
NCT03932773Recruiting
Check rTMS treatment for combat-related PTSD in veterans

This trial tests whether a non-drug brain stimulation treatment (rTMS) can reduce symptoms of PTSD in veterans who were exposed to post-9/11 combat trauma. It may help by improving PTSD symptoms, but you must meet safety rules—especially related to seizure risk.

Tallahassee, Florida
NCT07187011Not yet recruiting· Phase 2
Study of PT150 for PTSD in veterans

This study tests a new oral medication called PT150 to see if it helps reduce PTSD symptoms in Veterans. Participation involves taking the medication, regular check-ups, and questionnaires.

San Diego, California

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.